Latest news
VERU INC. 3Q 2026: Revenue $0 Net loss $6.99M, EPS ($0.3) — 10-Q Summary - TradingViewTradingView · Mon, 10 Aug 2026 13:01:01 GMTLilly's weight-loss pill gets UK regulator's nod - TradingViewTradingView · Mon, 10 Aug 2026 11:53:44 GMTUK’s MHRA Authorises Orforglipron For Weight Management And Type 2 Diabetes - TradingViewTradingView · Mon, 10 Aug 2026 11:34:05 GMTVeru Reports Q3 FY2026: Net Loss $7.0M, Cash $23.9M; PLATEAU Trial Fully Enrolled - TradingViewTradingView · Mon, 10 Aug 2026 11:03:01 GMTOzempic For $50 a Month? Amazon Pharmacy Rolls Out Cheap Weight-Loss Drugs for Medicare Patients - TradingViewTradingView · Fri, 07 Aug 2026 11:18:42 GMTApyx Medical Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 22:04:08 GMTStructure Therapeutics posts $106.2M Q2 net loss, $1.34B cash; doses first patients in Phase 3 aleniglipron - TradingViewTradingView · Thu, 06 Aug 2026 20:35:29 GMTMetaVia Inc. Q2 2026: Net loss $5.3M, EPS $(0.90) — 10-Q Summary - TradingViewTradingView · Thu, 06 Aug 2026 20:35:07 GMT